Health Care • Industrial Specialties
$448.76 ▲ +4.58
(+1.03%)
MKT CAP: $155.56B • VOL: 1.89M
52W L $329 52W H $604
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$377
MEDIAN
$503
MEAN
$512
HIGH
$610
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE ISRG TAPE
ISRG // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $543.00 | $516.07 | 2025-02-14 | $408.37 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $565.44 | $529.54 | 2025-02-06 | $421.83 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $511.59 | $493.64 | 2025-01-29 | $430.81 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $457.74 | — | 2025-01-17 | $439.78 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $394.91 | $426.32 | 2025-01-09 | $399.40 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $534.02 | $466.71 | 2024-12-18 | $390.42 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $435.30 | $453.25 | 2024-12-04 | $417.35 | -4.3% | 48% | C |